EDIT vs INVH · rev $32.3M vs P/E 42, rev $2.62B
Editas Medicine Inc (EDIT) versus Invitation Homes Inc (INVH) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported INVH revenue for 2024-12-31 was $2.62B. Net income was $455.4M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
EDIT currently screens at market cap $375.2M. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Not investment advice. Open the EDIT and INVH stock pages for the full models.
Not investment advice.